RSS Items

US law firm is winning coveted mandates for blue-chip clients in Britain

Philip Ball demotes the role of the double helix molecule, arguing that biology is far messier and marvellous than many scientists suspected

BHP has another week to convince Anglo’s board on the merits of its £39bn deal

He turned a commodities fortune into a sporting empire. Now sovereign wealth is rewriting the rules of the game

Disastrous UK mini-Budget of 2022 proves cautionary tale for US government

We should at least be alive to the risks of a reckoning

Equities investors seem unfazed by the risk that tariffs and tax cuts will push up inflation and deficits. But fears are rising

Economists debate whether the real interest rate seen as key to balancing economies has risen from pre-Covid lows

Also in this newsletter: companies struggle to prepare for environmental reporting rules

The cancer support centres now help more than 300,000 people every year. Fiona Golfar is one of them